Taiwan Industry Reports
Industry Type:   Title:  

Raw Material Medicine Manufacturing US$ 100
Jul-2023 Doc #38449
Printed Page Length : 14 pages
Number of Tables : 2
Number of Figures: 2
Market Overview
Taiwan’s domestic sales and export sales of active pharmaceutical ingredients for epidemics will weaken. Moreover, Chinese firms will improve their competitive edge, while the baseline is high, suggesting the industry climate will ease in the second half of 2023.

Copyright (c) 2018 All Rights Reserved by
Taiwan Institute of Economic Research
Taiwan Industry Economics Services
Address: 4Fl., 16-8, Tehui St., Taipei, Taiwan
TEL: 886-2-25865000 ext469; FAX: 886-2-25935543